Taiho Pharmaceutical

Taiho Pharmaceutical Co., Ltd. (大鵬薬品工業, Taihō Yakuhin Kōgyō) is a Japanese pharmaceutical company, subsidiary of Otsuka Holdings. The company focuses on developing cancer treatments. Taiho is headquartered in Tokyo, Japan. Taiho is an R&D-driven specialty pharma focusing on the three fields of oncology, allergies and immunology, and urology. In March 2013, Taiho has over 2,500 employees worldwide and achieved US$1.3 billion in revenue during the 2012 fiscal year.

Taiho Pharmaceutical

Taiho Pharmaceutical Co., Ltd. (大鵬薬品工業, Taihō Yakuhin Kōgyō) is a Japanese pharmaceutical company, subsidiary of Otsuka Holdings. The company focuses on developing cancer treatments. Taiho is headquartered in Tokyo, Japan. Taiho is an R&D-driven specialty pharma focusing on the three fields of oncology, allergies and immunology, and urology. In March 2013, Taiho has over 2,500 employees worldwide and achieved US$1.3 billion in revenue during the 2012 fiscal year.